Ischemic Stroke on Optimal Anticoagulation with Novel-Oral Anticoagulants Compared with Warfarin

Abstract

Get full access to this article

View all access options for this article.

References

Douxfils

Buckinx

Mullier

. Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: A systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 2014; 3:e000515.

Caprio

F.Z.

Bernstein

R.A.

Alberts

M.J.

. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections. Cerebrovasc Dis 2014; 38:247–53.

McBane

R.D.

2nd Hassinger

N.L.

Grill

D.E.

Chesebro

J.H.

The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury. J Thromb Haemost 2004; 2:1834–41.

Renda

Malatesta

Lanuti

Bucciarelli

Candelori

Morett

Effects of the direct thrombin inhibitor dabigatran etexilate vs warfarin on platelet function in patients with atrial fibrillation. Eur Heart J 2013. doi: http://dx.doi.org/10.1093/eurheartj/eht308.P1430.